{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:58:13Z","timestamp":1793750293035,"version":"4.6.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","award":["75A50121C00087"],"award-info":[{"award-number":["75A50121C00087"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021704","name":"Administration for Strategic Preparedness and Response","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017443","name":"Joint Program Executive Office for Chemical Biological Radiological and Nuclear Defense","doi-asserted-by":"publisher","award":["MCDC2204\\u2010001"],"award-info":[{"award-number":["MCDC2204\\u2010001"]}],"id":[{"id":"10.13039\/100017443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jconrel.2025.114054","type":"journal-article","created":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T14:22:47Z","timestamp":1753021367000},"page":"114054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity"],"prefix":"10.1016","volume":"385","author":[{"given":"Wynton D.","family":"McClary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin S.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine F.","family":"Jennewein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasneet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Beaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Ykema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Melief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Battisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan N.","family":"Kasal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airn Tolnay","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Casper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"Gerhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114054_bb0005","doi-asserted-by":"crossref","first-page":"2300001","DOI":"10.2807\/1560-7917.ES.2023.28.3.2300001","article-title":"Highly pathogenic avian influenza A(H5N1) virus infection in farmed minks, Spain, October 2022","volume":"28","author":"Ag\u00fcero","year":"2023","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jconrel.2025.114054_bb0010","first-page":"1","article-title":"The global H5N1 influenza panzootic in mammals","author":"Peacock","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114054_bb0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1473-3099(24)00238-X","article-title":"What is the pandemic potential of avian influenza a(H5N1)?","volume":"24","author":"Diseases","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.114054_bb0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/pathogens12020168","article-title":"Zoonotic mutation of highly pathogenic avian influenza H5N1 virus identified in the brain of multiple wild carnivore species","volume":"12","author":"Vreman","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.jconrel.2025.114054_bb0025","doi-asserted-by":"crossref","first-page":"102676","DOI":"10.1016\/j.tmaid.2023.102676","article-title":"Predicting the next pandemic: VACCELERATE ranking of the World Health Organization\u2019s Blueprint for Action to Prevent Epidemics","volume":"57","author":"Salmanton-Garc\u00eda","year":"2024","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.114054_bb0030","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1056\/NEJMc2102507","article-title":"Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated persons","volume":"385","author":"Kissler","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114054_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120686","article-title":"Nasal vaccination against SARS-CoV-2: synergistic or alternative to intramuscular vaccines?","volume":"603","author":"Tiboni","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114054_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010802","article-title":"Infectious viral shedding of SARS-CoV-2 Delta following vaccination: a longitudinal cohort study","volume":"18","author":"Garcia-Knight","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2025.114054_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.957107","article-title":"Mucosal immunity: the missing link in comprehending SARS-CoV-2 infection and transmission","volume":"13","author":"Russell","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114054_bb0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.hlife.2023.12.005","article-title":"Mucosal vaccine development for respiratory viral infections","volume":"2","author":"Lin","year":"2024","journal-title":"hLife"},{"key":"10.1016\/j.jconrel.2025.114054_bb0080","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114054_bb0085","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4161\/hv.25458","article-title":"Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults","volume":"9","author":"Ainai","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2025.114054_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121180","article-title":"Intranasal vaccine: factors to consider in research and development","volume":"609","author":"Xu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114054_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263861","article-title":"Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2","volume":"17","author":"Nickel","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.114054_bb0100","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1038\/s41467-024-50087-5","article-title":"Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines","volume":"15","author":"Dong","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114054_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01596-23","volume":"98","author":"Quadiri","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2025.114054_bb0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"COVE study group, efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114054_bb0115","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114054_bb0120","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.ymthe.2018.07.010","article-title":"A nanostructured lipid carrier for delivery of a replicating viral RNA provides single, low-dose protection against zika","volume":"26","author":"Erasmus","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114054_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.omtm.2022.03.009","article-title":"A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery","volume":"25","author":"Gerhardt","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2025.114054_bb0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41541-022-00549-y","article-title":"A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability","volume":"7","author":"Voigt","year":"2022","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.jconrel.2025.114054_bb0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/pharmaceutics16010131","article-title":"Chemistry and art of developing lipid nanoparticles for biologics delivery: focus on development and scale-up","volume":"16","author":"John","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114054_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.910136","article-title":"Heterologous saRNA prime, DNA dual-antigen boost SARS-CoV-2 vaccination elicits robust cellular immunogenicity and cross-variant neutralizing antibodies","volume":"13","author":"Rice","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114054_bb0145","author":"ImmunityBio, Inc"},{"key":"10.1016\/j.jconrel.2025.114054_bb0065","series-title":"Intranasal Self-Amplifying RNA SARS-CoV-2 Vaccine Produces Protective Respiratory and Systemic Immunity and Prevents Viral Transmission","author":"Jennewein","year":"2024"},{"key":"10.1016\/j.jconrel.2025.114054_bb0150","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114054_bb0155","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/polym15071615","article-title":"The role of Mucoadhesion and Mucopenetration in the immune response induced by polymer-based mucosal adjuvants","volume":"15","author":"Vasquez-Mart\u00ednez","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2025.114054_bb0160","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114054_bb0165","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/adma.201201800","article-title":"Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery","volume":"24","author":"Ensign","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114054_bb0170","series-title":"An intranasal, NLC-delivered self-amplifying RNA vaccine establishes protective immunity against pre-pandemic H5N1 and H7N9 influenza","author":"Ykema","year":"2025"},{"key":"10.1016\/j.jconrel.2025.114054_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.physd.2006.07.024","article-title":"An introduction to mathematical models of coagulation\u2013fragmentation processes: a discrete deterministic mean-field approach","volume":"222","author":"Wattis","year":"2006","journal-title":"Physica D"},{"key":"10.1016\/j.jconrel.2025.114054_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","article-title":"Automated molecular microscopy: the new Leginon system","volume":"151","author":"Suloway","year":"2005","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jconrel.2025.114054_bb0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/pro.3967","article-title":"Leginon: new features and applications","volume":"30","author":"Cheng","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.jconrel.2025.114054_bb0190","series-title":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Guide for the Care and Use of Laboratory Animals, Eighth","year":"2011"},{"key":"10.1016\/j.jconrel.2025.114054_bb0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41541-023-00608-y","article-title":"Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions","volume":"8","author":"Fisher","year":"2023","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.jconrel.2025.114054_bb0200","doi-asserted-by":"crossref","first-page":"17585","DOI":"10.1073\/pnas.1207308109","article-title":"Adjuvant solution for pandemic influenza vaccine production","volume":"109","author":"Clegg","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.114054_bb0205","doi-asserted-by":"crossref","first-page":"46426","DOI":"10.1038\/srep46426","article-title":"A formulated TLR7\/8 agonist is a flexible, highly potent and effective adjuvant for pandemic influenza vaccines","volume":"7","author":"Van Hoeven","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114054_bb0210","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/mabi.201300046","article-title":"The effect of N\/P ratio on the in vitro and in vivo interaction properties of PEGylated poly(2-(dimethylamino)ethyl methacrylate)-based siRNA complexes","volume":"13","author":"Gary","year":"2013","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2025.114054_bb0215","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1021\/acs.jpcb.9b07031","article-title":"Polyethylenimine\u2013DNA ratio strongly affects their nanoparticle formation: a large-scale coarse-grained molecular dynamics study","volume":"123","author":"Mahajan","year":"2019","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jconrel.2025.114054_bb0220","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11095-010-0073-2","article-title":"Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates","volume":"27","author":"Filipe","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.114054_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110610","article-title":"Cancer gene therapy mediated by RALA\/plasmid DNA vectors: nitrogen to phosphate groups ratio (N\/P) as a tool for tunable transfection efficiency and apoptosis","volume":"185","author":"Neves","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.114054_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125324","article-title":"Optimizing mRNA delivery: a microfluidic exploration of DOTMA vs. DOTAP lipid nanoparticles for GFP expression on human PBMCs and THP-1 cell line","volume":"672","author":"Lamparelli","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114054_bb0235","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(20)31866-3","article-title":"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia","volume":"396","author":"Logunov","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114054_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-024-00912-1","article-title":"Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine","volume":"9","author":"Bissett","year":"2024","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.jconrel.2025.114054_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2022.05.002","article-title":"The unfulfilled potential of mucosal immunization","volume":"150","author":"Baker","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114054_bb0250","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","article-title":"Current prospects and future challenges for nasal vaccine delivery","volume":"13","author":"Yusuf","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2025.114054_bb0255","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1021\/acs.molpharmaceut.2c00032","article-title":"Optimization of lipid nanoparticles for saRNA expression and cellular activation using a design-of-experiment approach","volume":"19","author":"Ly","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.114054_bb0260","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/infdis\/jiu522","article-title":"Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion","volume":"211","author":"Bogers","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.114054_bb0265","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/dvg.22871","article-title":"Movement of regulatory RNA between animal cells","volume":"53","author":"Jose","year":"2015","journal-title":"Genesis"},{"key":"10.1016\/j.jconrel.2025.114054_bb0270","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(97)01283-0","article-title":"Cationic lipids destabilize lysosomal membrane in vitro","volume":"417","author":"Wattiaux","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2025.114054_bb0275","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.gt.3301506","article-title":"On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids","volume":"8","author":"Hafez","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2025.114054_bb0280","doi-asserted-by":"crossref","first-page":"e00414","DOI":"10.1128\/CVI.00414-16","article-title":"Comparisons of the humoral and cellular immune responses induced by live attenuated influenza vaccine and inactivated influenza vaccine in adults","volume":"24","author":"Hoft","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jconrel.2025.114054_bb0285","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist\u00ae; Fluenz\u2122): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2025.114054_bb0290","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijid.2014.05.016","article-title":"T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine","volume":"27","author":"Li","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.114054_bb0295","doi-asserted-by":"crossref","first-page":"iqac004","DOI":"10.1093\/oxfimm\/iqac004","article-title":"Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets","volume":"3","author":"McKay","year":"2022","journal-title":"Oxf. Open Immunol."},{"key":"10.1016\/j.jconrel.2025.114054_bb0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4161\/rna.27717","article-title":"Toward a crystal-clear view of the viral RNA sensing and response by RIG-I-like receptors","volume":"11","author":"Luo","year":"2014","journal-title":"RNA Biol."},{"key":"10.1016\/j.jconrel.2025.114054_bb0305","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114054_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-024-00932-x","article-title":"Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza","volume":"9","author":"Cui","year":"2024","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.jconrel.2025.114054_bb0315","first-page":"L833","article-title":"Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia","volume":"282","author":"Southam","year":"2002","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jconrel.2025.114054_bb0320","doi-asserted-by":"crossref","first-page":"13879","DOI":"10.1128\/JVI.02341-14","article-title":"Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume","volume":"88","author":"Moore","year":"2014","journal-title":"J. Virol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:13:48Z","timestamp":1778944428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925006765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":60,"alternative-id":["S0168365925006765"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114054","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114054"}}